A Case of Gastrointestinal Hemorrage Due to Warfarin Interaction with Nalidixic Acid Resulting in Massive Blood Loss
About the Authors
D. A. Sychev
I.M. Sechenov Moscow Medical Academy, Moscow; Institute of Clinical Pharmacology, Scientific Centre for Investigation of Medicinal Products, Moscow; Medsantrud State Clinical Hospital No. 23, Moscow
Russian Federation
Russian Federation
O. A. Nizovtseva
I.M. Sechenov Moscow Medical Academy, Moscow; Institute of Clinical Pharmacology, Scientific Centre for Investigation of Medicinal Products, Moscow; Medsantrud State Clinical Hospital No. 23, Moscow
Russian Federation
Russian Federation
G. S. Anikin
I.M. Sechenov Moscow Medical Academy, Moscow; Institute of Clinical Pharmacology, Scientific Centre for Investigation of Medicinal Products, Moscow; Medsantrud State Clinical Hospital No. 23, Moscow
Russian Federation
Russian Federation
E. F. Burian
I.M. Sechenov Moscow Medical Academy, Moscow; Institute of Clinical Pharmacology, Scientific Centre for Investigation of Medicinal Products, Moscow; Medsantrud State Clinical Hospital No. 23, Moscow
Russian Federation
Russian Federation
I. V. Butyakova
I.M. Sechenov Moscow Medical Academy, Moscow; Institute of Clinical Pharmacology, Scientific Centre for Investigation of Medicinal Products, Moscow; Medsantrud State Clinical Hospital No. 23, Moscow
Russian Federation
Russian Federation
I. V. Ignatiev
I.M. Sechenov Moscow Medical Academy, Moscow; Institute of Clinical Pharmacology, Scientific Centre for Investigation of Medicinal Products, Moscow; Medsantrud State Clinical Hospital No. 23, Moscow
Russian Federation
Russian Federation
S. YU. Serebrova
I.M. Sechenov Moscow Medical Academy, Moscow; Institute of Clinical Pharmacology, Scientific Centre for Investigation of Medicinal Products, Moscow; Medsantrud State Clinical Hospital No. 23, Moscow
Russian Federation
Russian Federation
D. A. Guzhev
I.M. Sechenov Moscow Medical Academy, Moscow; Institute of Clinical Pharmacology, Scientific Centre for Investigation of Medicinal Products, Moscow; Medsantrud State Clinical Hospital No. 23, Moscow
Russian Federation
Russian Federation
V. A. Dmitriev
I.M. Sechenov Moscow Medical Academy, Moscow; Institute of Clinical Pharmacology, Scientific Centre for Investigation of Medicinal Products, Moscow; Medsantrud State Clinical Hospital No. 23, Moscow
Russian Federation
Russian Federation
V. G. Kukes
I.M. Sechenov Moscow Medical Academy, Moscow; Institute of Clinical Pharmacology, Scientific Centre for Investigation of Medicinal Products, Moscow; Medsantrud State Clinical Hospital No. 23, Moscow
Russian Federation
Russian Federation
References
1. Vivian J.C. Liability for drug-drug interaction. US Pharm1996; 21: 93-95.
2. Hoffbrand B.I. Letter: Interaction of nalidixic acid and warfarin. Br Med J. 1974; 22: 2: 5920: 666.
3. Leor J., Levartowsky D., Sharon C. Interaction between nalidixic acid and warfarin. Ann Intern Med. 1987;107: 4: 601.
4. Edwards D.J., Bowles S.K., Svensson C.K., Rybak M.J. Inhibition of drug metabolism by quinolone antibiotics. Clin Pharmacokinet. 1988; 15: 3: 194-204.
5. Sellers E.M., Koch-Weser J. Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids. Clin Pharmacol Ther 1970; 11: 4: 524-529.
6. Yale S.H., Glurich I. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6 and 2C9. J Altern Compement Med. 2005 Jun; 11: 3: 433-439.
7. Кукес В.Г., Грачев С.В., Сычев Д.А., Раменская Г.В. Метаболизм лекарственных средств: научные основы персонализированной медицины. М.: 2008; 304.
8. http://www.regmed.ru
9. Практическое руководство по антиинфекционной химотерапии / Под ред. Страчунского Л.С., Белоусова Ю.Б., Козлова С.Н. http://www.antibiotic.ru/ab/drug_interactions.shtml
Review
For citations:
Sychev D.A., Nizovtseva O.A., Anikin G.S., Burian E.F., Butyakova I.V., Ignatiev I.V., Serebrova S.Yu., Guzhev D.A., Dmitriev V.A., Kukes V.G. A Case of Gastrointestinal Hemorrage Due to Warfarin Interaction with Nalidixic Acid Resulting in Massive Blood Loss. Antibiot Khimioter = Antibiotics and Chemotherapy. 2009;54(3-4):38-41. (In Russ.)
Views:
325
Email this article 